BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25052873)

  • 1. Hepcidin and GDF15 in anemia of multiple myeloma.
    Mei S; Wang H; Fu R; Qu W; Xing L; Wang G; Song J; Liu H; Li L; Wang X; Wu Y; Guan J; Ruan E; Shao Z
    Int J Hematol; 2014 Sep; 100(3):266-73. PubMed ID: 25052873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peripheral blood monocyte hepcidin in patients with multiple myeloma is associated with anemia of chronic disease].
    Han X; Zhou DB; Duan MH; Wang X; Zhang JP; Zhao YQ; Shen T; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):403-9. PubMed ID: 23628042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.
    Fujiwara T; Ikeda T; Nagasaka Y; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Tomosugi N; Harigae H
    PLoS One; 2013; 8(9):e75568. PubMed ID: 24086573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.
    Hong JH; Choi YK; Min BK; Park KS; Seong K; Lee IK; Kim JG
    Diabetes Res Clin Pract; 2015 Jul; 109(1):64-70. PubMed ID: 25998917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDF15 is related to anemia and hepcidin in kidney allograft recipients.
    Malyszko J; Koc-Zorawska E; Malyszko JS; Glowinska I; Mysliwiec M; Macdougall IC
    Nephron Clin Pract; 2013; 123(1-2):112-7. PubMed ID: 23797049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients.
    Ibricevic-Balic L; Icindic-Nakas E; Hasic S; Kiseljakovic E; Sofo-Hafizovic A; Balic S
    Med Arch; 2016 Dec; 70(6):429-432. PubMed ID: 28210014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.
    Corre J; Labat E; Espagnolle N; Hébraud B; Avet-Loiseau H; Roussel M; Huynh A; Gadelorge M; Cordelier P; Klein B; Moreau P; Facon T; Fournié JJ; Attal M; Bourin P
    Cancer Res; 2012 Mar; 72(6):1395-406. PubMed ID: 22301101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of recombinant human erythropoietin on hepcidin mRNA expression in patients with multiple myeloma].
    Wang FD; Zhou DB; Li SL; Wang X; Zhang JP; Duan MH; Shen T; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):390-4. PubMed ID: 21518494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.
    Theurl M; Nairz M; Schroll A; Sonnweber T; Asshoff M; Haschka D; Seifert M; Willenbacher W; Wilflingseder D; Posch W; Murphy AT; Witcher DR; Theurl I; Weiss G
    Haematologica; 2014 Sep; 99(9):1516-24. PubMed ID: 24895335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.
    Theurl I; Finkenstedt A; Schroll A; Nairz M; Sonnweber T; Bellmann-Weiler R; Theurl M; Seifert M; Wroblewski VJ; Murphy AT; Witcher D; Zoller H; Weiss G
    Br J Haematol; 2010 Feb; 148(3):449-55. PubMed ID: 19863534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin is a key mediator of anemia of inflammation in Crohn's disease.
    Basseri RJ; Nemeth E; Vassilaki ME; Basseri B; Enayati P; Shaye O; Bourikas LA; Ganz T; Papadakis KA
    J Crohns Colitis; 2013 Sep; 7(8):e286-91. PubMed ID: 23219355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia.
    Cheng PP; Jiao XY; Wang XH; Lin JH; Cai YM
    Clin Exp Med; 2011 Mar; 11(1):33-42. PubMed ID: 20499129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers.
    Goetze O; Schmitt J; Spliethoff K; Theurl I; Weiss G; Swinkels DW; Tjalsma H; Maggiorini M; Krayenbühl P; Rau M; Fruehauf H; Wojtal KA; Müllhaupt B; Fried M; Gassmann M; Lutz T; Geier A
    Hepatology; 2013 Dec; 58(6):2153-62. PubMed ID: 23787477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.
    Finkenstedt A; Widschwendter A; Brasse-Lagnel CG; Theurl I; Hubalek M; Dieplinger H; Tselepis C; Ward DG; Vogel W; Zoller H
    Blood Cells Mol Dis; 2012 Apr; 48(4):233-7. PubMed ID: 22365732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.
    Tamary H; Shalev H; Perez-Avraham G; Zoldan M; Levi I; Swinkels DW; Tanno T; Miller JL
    Blood; 2008 Dec; 112(13):5241-4. PubMed ID: 18824595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferritin levels and hepcidin mRNA expression in peripheral mononuclear cells from anemic type 2 diabetic patients.
    Andrews M; Arredondo M
    Biol Trace Elem Res; 2012 Oct; 149(1):1-4. PubMed ID: 22426798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma.
    Waterman GN; Yellin O; Swift RA; Mapes R; Eades B; Ackerman E; Berenson JR
    Ann Hematol; 2011 Feb; 90(2):193-200. PubMed ID: 20809423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum hepcidin levels in geriatric patients with iron deficiency anemia or anemia of chronic diseases].
    Röhrig G; Rappl G; Vahldick B; Kaul I; Schulz RJ
    Z Gerontol Geriatr; 2014 Jan; 47(1):51-6. PubMed ID: 23743883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.